12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
Objectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/1/e001628.full |
id |
doaj-03124d20a9cb4ec5bd839ecccf7dc00d |
---|---|
record_format |
Article |
spelling |
doaj-03124d20a9cb4ec5bd839ecccf7dc00d2021-09-26T04:00:05ZengBMJ Publishing GroupRMD Open2056-59332021-04-017110.1136/rmdopen-2021-00162812-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this targetTill Uhlig0Espen A Haavardsholm1Lars F Karoliussen2professorprofessor1 Rheumatology, Diakonhjemmet Hospital, Oslo, NorwayObjectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare and sUA >360 µmol/L (>6 mg/dL) were consecutively included in a single-centre study and managed with a treat-to-target approach combining nurse-led information about gout with ULT. All patients were assessed with tight controls at baseline, 1, 2, 3, 6, 9 and 12 months including clinical examination, information on demographics, lifestyle, self-efficacy and beliefs about medicines. The treatment target was sUA <360 µmol/L and multivariable logistic regression was used to identify predictors of target attainment with ORs and 95% CIs.Results Of 211 patients (mean age 56.4 years, disease duration 7.8 years, 95% males), 186 completed the 12-month study. Mean sUA levels decreased from baseline mean 500 to 311 µmol/L at 12 months with 85.5% achieving the treatment target. Alcohol consumption at least weekly versus less frequently (OR 0.14; 95% CI 0.04 to 0.55) as well as beliefs in overuse of medicines (OR per unit 0.77; 95 CI 0.62 to 0.94) decreased the chance of reaching the treatment target, while higher self-efficacy for arthritis symptoms (OR 1.49 per 10 units; 95% CI 1.09 to 2.05) increased the likelihood.Conclusions This study shows that target sUA can be achieved with ULT in most patients. Less self-reported alcohol consumption, low beliefs in overuse of medicines and higher self-efficacy are associated with treatment success.https://rmdopen.bmj.com/content/7/1/e001628.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Till Uhlig Espen A Haavardsholm Lars F Karoliussen |
spellingShingle |
Till Uhlig Espen A Haavardsholm Lars F Karoliussen 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target RMD Open |
author_facet |
Till Uhlig Espen A Haavardsholm Lars F Karoliussen |
author_sort |
Till Uhlig |
title |
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target |
title_short |
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target |
title_full |
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target |
title_fullStr |
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target |
title_full_unstemmed |
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target |
title_sort |
12-month results from the real-life observational treat-to-target and tight-control therapy nor-gout study: achievements of the urate target levels and predictors of obtaining this target |
publisher |
BMJ Publishing Group |
series |
RMD Open |
issn |
2056-5933 |
publishDate |
2021-04-01 |
description |
Objectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare and sUA >360 µmol/L (>6 mg/dL) were consecutively included in a single-centre study and managed with a treat-to-target approach combining nurse-led information about gout with ULT. All patients were assessed with tight controls at baseline, 1, 2, 3, 6, 9 and 12 months including clinical examination, information on demographics, lifestyle, self-efficacy and beliefs about medicines. The treatment target was sUA <360 µmol/L and multivariable logistic regression was used to identify predictors of target attainment with ORs and 95% CIs.Results Of 211 patients (mean age 56.4 years, disease duration 7.8 years, 95% males), 186 completed the 12-month study. Mean sUA levels decreased from baseline mean 500 to 311 µmol/L at 12 months with 85.5% achieving the treatment target. Alcohol consumption at least weekly versus less frequently (OR 0.14; 95% CI 0.04 to 0.55) as well as beliefs in overuse of medicines (OR per unit 0.77; 95 CI 0.62 to 0.94) decreased the chance of reaching the treatment target, while higher self-efficacy for arthritis symptoms (OR 1.49 per 10 units; 95% CI 1.09 to 2.05) increased the likelihood.Conclusions This study shows that target sUA can be achieved with ULT in most patients. Less self-reported alcohol consumption, low beliefs in overuse of medicines and higher self-efficacy are associated with treatment success. |
url |
https://rmdopen.bmj.com/content/7/1/e001628.full |
work_keys_str_mv |
AT tilluhlig 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget AT espenahaavardsholm 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget AT larsfkaroliussen 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget |
_version_ |
1716868515572482048 |